Of all primary cancers in humans, melanoma has the highest propensity to metastasize to the brain. The prognosis of patients with this disease is extremely poor. Due to its radioresistance and poor response to existing chemotherapeutic regimes, no treatment options other than surgical extirpation, when feasible, have been shown to be effective. An understanding of the underlying tumor biology therefore remains the cornerstone of offering new hope in the treatment. In this review, we comment on the current treatment strategies for melanoma brain metastases and summarize some recent experimental findings from our laboratory with potential for the development of target specific antitumor therapies.12 page(s
Copyright © 2013 Dionysis Papadatos-Pastos et al. This is an open access article distributed under t...
Of all skin cancers, melanoma is the most fatal. Of all cancer types, melanoma is also the cancer wi...
Background. Historically, melanoma with brain metastases has a poor prognosis. In this retrospective...
Of all primary cancers in humans, melanoma has the highest propensity to metastasize to the brain. T...
The development of brain metastases in patients with advanced stage melanoma is common, but the mole...
Brain metastases are common in advanced melanoma and cause death in \u3e50% of patients. Until recen...
Brain metastases are a major clinical challenge occurring in up to 60% of patients suffering from me...
Melanoma is the sixth most common form of cancer in the United States. Moreover, it is the third mos...
Metastases from cells outside of the central nervous system are the most common cancer found in the ...
AIM: Improved systemic treatment has improved the prognosis of metastatic melanoma (MM). However, br...
Patients with brain metastases from malignant melanoma historically have a very poor outcome. Surger...
Melanoma brain metastases (MBM) are common and associated with a particularly poor prognosis; they d...
Brain metastases are frequent and dreadful complications of cancer especially lung, breast, colorect...
Brain metastasis is emerging as a unique entity in oncology based on its particular biology and, con...
The management of melanoma brain metastases (MBM) includes different therapeutic modalities, such as...
Copyright © 2013 Dionysis Papadatos-Pastos et al. This is an open access article distributed under t...
Of all skin cancers, melanoma is the most fatal. Of all cancer types, melanoma is also the cancer wi...
Background. Historically, melanoma with brain metastases has a poor prognosis. In this retrospective...
Of all primary cancers in humans, melanoma has the highest propensity to metastasize to the brain. T...
The development of brain metastases in patients with advanced stage melanoma is common, but the mole...
Brain metastases are common in advanced melanoma and cause death in \u3e50% of patients. Until recen...
Brain metastases are a major clinical challenge occurring in up to 60% of patients suffering from me...
Melanoma is the sixth most common form of cancer in the United States. Moreover, it is the third mos...
Metastases from cells outside of the central nervous system are the most common cancer found in the ...
AIM: Improved systemic treatment has improved the prognosis of metastatic melanoma (MM). However, br...
Patients with brain metastases from malignant melanoma historically have a very poor outcome. Surger...
Melanoma brain metastases (MBM) are common and associated with a particularly poor prognosis; they d...
Brain metastases are frequent and dreadful complications of cancer especially lung, breast, colorect...
Brain metastasis is emerging as a unique entity in oncology based on its particular biology and, con...
The management of melanoma brain metastases (MBM) includes different therapeutic modalities, such as...
Copyright © 2013 Dionysis Papadatos-Pastos et al. This is an open access article distributed under t...
Of all skin cancers, melanoma is the most fatal. Of all cancer types, melanoma is also the cancer wi...
Background. Historically, melanoma with brain metastases has a poor prognosis. In this retrospective...